Literature DB >> 3053230

Cellular models for the detection and evaluation of drugs that modulate human phagocyte activity.

M Baggiolini1, B Dewald.   

Abstract

Simple testing models have been developed for the evaluation of chemical or biological compounds that modulate the activity of human phagocytes. Human neutrophils from buffy coats of donor blood are used. They are stimulated with receptor agonists, and the effects of test compounds on exocytosis of different enzymes, the generation of superoxide (respiratory burst), and cytotoxicity are quantified. All assays are performed in microtiter plates and the responses are evaluated by multi-well photometry or fluorimetry. The models are apt to detect compounds acting on phagocytes as agonists or antagonists, signal transduction activators or inhibitors and primers of agonist responses, and to assess cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053230     DOI: 10.1007/BF01941181

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  34 in total

Review 1.  Effects of PAF on neutrophils and mononuclear phagocytes.

Authors:  M Baggiolini; B Dewald; M Thelen
Journal:  Prog Biochem Pharmacol       Date:  1988

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

Review 3.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 4.  Phagocytes use oxygen to kill bacteria.

Authors:  M Baggiolini
Journal:  Experientia       Date:  1984-09-15

5.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

Authors:  A Walz; P Peveri; H Aschauer; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

6.  The onset of the respiratory burst in human neutrophils. Real-time studies of H2O2 formation reveal a rapid agonist-induced transduction process.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

7.  Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analogues.

Authors:  M Baggiolini; B Dewald; J Schnyder; W Ruch; P H Cooper; T G Payne
Journal:  Exp Cell Res       Date:  1987-04       Impact factor: 3.905

8.  Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  Anal Biochem       Date:  1987-09       Impact factor: 3.365

9.  Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes.

Authors:  B Dewald; R Rindler-Ludwig; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

10.  Absence of platelet membrane glycoproteins IIb/IIIa from monocytes.

Authors:  K J Clemetson; J L McGregor; R P McEver; Y V Jacques; D F Bainton; W Domzig; M Baggiolini
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  3 in total

1.  Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.

Authors:  B D Car; M Baggiolini; A Walz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

2.  Changes in inositol 1,4,5-trisphosphate mass in agonist-stimulated human neutrophils.

Authors:  D A Fruman; D A Gamache; M J Ernest
Journal:  Agents Actions       Date:  1991-09

3.  Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Authors:  P Kernen; M P Wymann; V von Tscharner; D A Deranleau; P C Tai; C J Spry; C A Dahinden; M Baggiolini
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.